市場調查報告書
商品編碼
1350993
2023-2030 年全球人工智慧 (AI) 醫學寫作市場Global Artificial Intelligence (AI) in Medical Writing Market 2023-2030 |
預計在預測期內(2023-2030 年),全球醫學寫作市場中的人工智慧將以 16.1% 的年複合成長率成長。醫學寫作中的人工智慧是一個高度專業化的領域,涵蓋內容寫作和臨床研究的藝術和科學。它涉及結構良好的科學資源的製作,包括臨床研究論文、醫療保健產業的網路內容、期刊和期刊等。與傳統方法相比,人工智慧利用稱為自然語言生成 (NLG) 的軟體流程的功能,能夠在顯著縮短的時間內產生複雜的文件(從幾週縮短到幾天)。這種加速的生產時間表隨後增加了提交和核准流程,使製藥和通訊公司受益。這種效率提升成為支持全球市場成長的關鍵驅動力。
全球醫學寫作市場中的人工智慧按類型和最終用戶進行細分。依類型,市場分為臨床寫作、類型寫作、科學寫作等。根據最終用戶,市場細分為醫療器材、製藥、生物技術等。其中,臨床寫作細分市場預計將佔據相當大的市場佔有率。這種成長可歸因於臨床寫作在醫療專業人員的日常實踐中發揮的重要作用。熟練的臨床作家必須對臨床情況和所涉及的語言複雜性有全面的了解。臨床試驗數量的不斷增加進一步加劇了這種情況,導致醫學寫作中對人工智慧驅動解決方案的需求激增。
在最終用戶中,醫藥細分市場預計將在全球人工智慧醫學寫作市場中佔據相當大的佔有率。此細分市場的成長歸因於人工智慧在醫療領域的進步和精確度。這項進展促使製藥業的重要參與者專注於在其組織內投資有效的人工智慧寫作解決方案。許多公司也與人工智慧公司建立合作關係,這是進一步推動市場擴張的策略舉措。例如,2022 年 6 月,專門從事人工智慧和自然語言處理 (NLP) 的公司 Yesop 與賽諾菲合作,以增強安全報告的自動化。賽諾菲目前正在使用 Yseop 平台處理藥品和疫苗使用案例,以加快臨床試驗檔案提交工作流程。
全球人工智慧醫學寫作市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國) 、日本、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於醫療保健支出不斷增加,加上對高效醫療保健解決方案的需求不斷成長,預計亞太地區將在全球市場中佔據顯著佔有率。此外,中國、日本、韓國和印度等國家技術進步迅速,一直處於人工智慧技術進步的前沿。
在所有地區中,北美地區預計在預測期內將以相當大的年複合成長率成長。區域成長歸因於監管標準的快速變化以及研發支出的不斷增加,這也是由於醫療保健支出的增加和對高效醫療保健解決方案的需求。近年來,隨著人工智慧技術的進步,包括自然語言處理(NLP)和機器學習(ML)等成功,製藥業已開始從資料技術中獲得更大的好處。人工智慧技術已經在臨床試驗中發揮實質作用,加快了研究進程,提高了結果的品質。 NLP 對於幫助從醫療保健生態系統中的資料寶庫(例如醫院資訊系統、保險索賠資料庫等)中提取現實世界資料(RWD)非常有幫助。
因此,該國在採用人工智慧寫作市場解決方案方面發生了重大轉變。
Title: Global Artificial Intelligence (AI) in Medical Writing Market Size, Share & Trends Analysis Report by Type (Clinical Writing, Type Writing, Scientific Writing, and Others), and by End User (Medical Devices, Pharmaceutical, Biotechnology, and Others),Forecast Period (2023-2030).
The global AI in medical writing market is anticipated to grow at a CAGR of 16.1% during the forecast period (2023-2030). AI in medical writing is a highly specialized field that encompasses the art and science of content writing and clinical research. It involves the production of well-structured scientific resources including clinical research papers, web content for the healthcare industry, periodicals, and journals, among others. Employing the capabilities of a software process called as natural language generation (NLG), AI has the ability to produce complex documents in a significantly reduced timeframe compared to conventional methods (from weeks down to mere days). This accelerated production timeline subsequently increases the submissions and approval processes, benefiting both pharmaceutical and communication companies. This efficiency gain becomes a pivotal driver supporting the global market's growth.
The global AI in medical writing market is segmented on the type, and end user. Based on the type, the market is sub- segmented into clinical writing, type writing, scientific writing, and others. Based on the end user, the market is sub-segmented into medical devices, pharmaceutical, biotechnology and others. Among the type, the clinical writing sub-segment is anticipated to hold a considerable share of the market. This growth can be attributed to the essential role that clinical writing plays in the daily practices of medical professionals. A proficient clinical writer must possess a comprehensive understanding of both the clinical landscape and the language intricacies involved. The escalating number of clinical trials further contributes to this scenario, creating a surge in the requirement for AI-powered solutions in medical writing.
Among the end user, the pharmaceutical sub-segment is expected to hold a considerable share of the global AI in medical writing market. The segmental growth is attributed to the advancements and precision achieved by AI in medical treatments. This progress has pushed significant players in the pharmaceutical industry to focus on investing in effective AI writing solutions within their organizations. Many are also forging partnerships with AI-based firms, a strategic move that further propels the expansion of the market. For instance, in June 2022, Yesop, a company specializing in AI and Natural Language Processing (NLP), partnered with Sanofi to enhance the automation of safety reports. Sanofi is now using the Yseop platform for pharma and vaccine used cases in a push to expedite clinical trial dossier submission workflows.
The global AI in medical writing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising expenditure in healthcare coupled with the growing demand for efficient healthcare solutions. Additionally, the rapid technological advancements in countries such as China, Japan, South Korea, and India have been at the forefront of technological advancements in AI.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to Regulatory standards have changed quickly, and spending on research and development has been rising constantly, also due to rising healthcare expenditure and demand for efficient healthcare solutions. With the advancement of artificial intelligence technology in recent years, including successes like natural language processing (NLP) and machine learning (ML), the pharmaceuticals industry has begun to realize greater benefits from data technology. AI technologies are already playing a substantive role in clinical trials, speeding the process of research, and enhancing the quality of results. NLP is of great benefit to help extract real world data (RWD) from the treasure troves of data that are in healthcare ecosystems, such as hospital information systems, insurance claim databases, etc.
Hence, there is considerable shift of the country towards the adoption of the AI writing market solutions.
The major companies serving the AI in medical writing market include: Parexel International Corporation., Trilogy Writing & Consulting GmbH, Freyr, Cactus Communications, and GENINVO, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Parexel International Corp. is applying AI technologies in clinical trials from the perspective of pharmacovigilance processes.